Literature DB >> 15134521

Mitochondrial superoxide dismutase: a promising target for new anticancer therapies.

Giovambattista Pani1, Renata Colavitti, Barbara Bedogni, Salvatore Fusco, Daniela Ferraro, Silvia Borrello, Tommaso Galeotti.   

Abstract

Compelling experimental and epidemiological evidence involves oxygen radicals in carcinogenesis, acting reactive oxygen species both as endogenous genotoxins during cell initiation and as messenger molecules in mitogenesis and in tumor promotion. Moreover, oxidants stimulate neoangiogenesis, which is a prerequisite for tumor growth. However, while several natural as well as synthetic antioxidant compounds appear to be chemopreventive in mutagenicity assays, antioxidant-based treatments for the prevention or cure of cancer have led to non-conclusive if not disappointing results. This is likely due to the fact that oxygen radicals have also a major role in the natural defences against the propagation of cancer cells, i.e. tumor cell apoptosis and immune surveillance, and mediate the beneficial cytotoxic effect of both the chemo-and radio-therapy. In recent years, the mitochondrial antioxidant enzyme, Manganous Superoxide Dismutase (MnSOD), has received a growing attention as a negative modulator of cellular apoptosis and as a survival factor for cancer cells. In fact, while overexpression of this enzyme in cancer cells decreases proliferation and tumor incidence in transgenic models, it is clear that even small amounts of this enzyme are crucial for cell resistance to inflammatory stimuli and anticancer drugs, and prevent oncogene-induced apoptosis triggered by the tumor suppressor protein p53. A previously unexpected oncogenic potential of MnSOD is also suggested by the elevated levels of this enzyme in several classes of human neoplasms, in a fashion which often correlates with the degree of their malignancy. This review focuses on the debated issue of the pro- and/or anti-tumoral effect of MnSOD, with special emphasis on recent observations suggesting that pharmacological inhibition of MnSOD may represent an effective strategy to selectively kill cancer cells and to circumvent their resistance to the commonly used anticancer treatments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134521     DOI: 10.2174/0929867043365297

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  30 in total

1.  Cancer phototherapy via selective photoinactivation of respiratory chain oxidase to trigger a fatal superoxide anion burst.

Authors:  Shengnan Wu; Feifan Zhou; Yanchun Wei; Wei R Chen; Qun Chen; Da Xing
Journal:  Antioxid Redox Signal       Date:  2013-10-05       Impact factor: 8.401

2.  Manganese superoxide dismutase: effect of the ala16val polymorphism on protein, activity, and mRNA levels in human breast cancer cell lines and stably transfected mouse embryonic fibroblasts.

Authors:  Britt L McAtee; James D Yager
Journal:  Mol Cell Biochem       Date:  2009-09-13       Impact factor: 3.396

3.  A unique model for SDH-deficient GIST: an endocrine-related cancer.

Authors:  James F Powers; Brent Cochran; James D Baleja; Hadley D Sikes; Xue Zhang; Inna Lomakin; Troy Langford; Kassi Taylor Stein; Arthur S Tischler
Journal:  Endocr Relat Cancer       Date:  2018-07-02       Impact factor: 5.678

Review 4.  Mitochondrial ROS control of cancer.

Authors:  María Del Pilar Sosa Idelchik; Ulrike Begley; Thomas J Begley; J Andrés Melendez
Journal:  Semin Cancer Biol       Date:  2017-04-23       Impact factor: 15.707

Review 5.  Exploring the electrostatic repulsion model in the role of Sirt3 in directing MnSOD acetylation status and enzymatic activity.

Authors:  Yueming Zhu; Seong-Hoon Park; Ozkan Ozden; Hyun-Seok Kim; Haiyan Jiang; Athanassios Vassilopoulos; Douglas R Spitz; David Gius
Journal:  Free Radic Biol Med       Date:  2012-06-23       Impact factor: 7.376

6.  Proteomic analyses of gastric cancer cells treated with vesicular stomatitis virus matrix protein.

Authors:  Dequan Zeng; Tao Zhang; Shengtao Zhou; Hao Hu; Jingyi Li; Kai Huang; Yunlong Lei; Kui Wang; Yong Zhao; Rui Liu; Qiu Li; Yanjun Wen; Canhua Huang
Journal:  Protein J       Date:  2011-06       Impact factor: 2.371

Review 7.  Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrence.

Authors:  Sarah Crawford
Journal:  Ther Adv Med Oncol       Date:  2014-03       Impact factor: 8.168

8.  Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells.

Authors:  Yong Xu; Fang Fang; Sanjit K Dhar; Antonio Bosch; William H St Clair; Edward J Kasarskis; Daret K St Clair
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

Review 9.  Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication.

Authors:  Minjong Lee; Jung-Hwan Yoon
Journal:  World J Biol Chem       Date:  2015-08-26

Review 10.  Manganese superoxide dismutase in cancer prevention.

Authors:  Delira Robbins; Yunfeng Zhao
Journal:  Antioxid Redox Signal       Date:  2013-07-18       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.